Inhibition of EZH2 in multidrug resistant B-cell lymphomas directed etoposide mediated DNA damage response towards a p53 dependent apoptotic response associated with the loss of MDMX and BCL-XL expression. Here, TP53 is linked to B-cell non-Hodgkin lymphoma.